Contract Research Organization (CRO) Services Market worth $125.95 billion in 2030 with 8.3% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Sept. 1, 2025 /PRNewswire/ -- The global Contract Research Organization Services Market, valued at US$79.10 billion in 2024, stood at US$84.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$125.95 billion by the end of the period. Factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market. Moreover, the upcoming therapeutic drugs patent cliff is fueling pharmaceutical companies to invest heavily in R&D activities and outsource their clinical trials to CROs. Additionally, the growing regulatory focus on patient diversity and data analysis offerings favoring customer reimbursement & market access strategy are other key growth opportunities.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167410116
Browse in-depth TOC on "Contract Research Organization Services Market"
626- Tables
57 - Figures
400 - Pages
By modality, the CRO services market is segmented into small molecules, biologics, medical devices, and biosimilars. The medical devices segment is projected to register the highest CAGR during the forecast period. The high growth rate of this segment is attributed to factors such as the high growth in medtech R&D and the stringent regulatory expectations for clinical evidence, post-market surveillance, and quality expectations. Moreover, rapid innovation in AI-enabled, wearable, structural-heart, neuromodulation, and robotics technologies is expanding trial volume and complexity, requiring CROs with device-specific expertise, therefore fueling the market growth of this segment.
By end users, the CRO services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies and academic institutes. The medical device companies' segment is expected to grow at the highest rate, owing to factors such as the increasing complexity and regulatory requirements associated with device development and approval, fueling demand for specialized CRO expertise to accelerate time-to-market. Additionally, many medical device companies are mid-sized or emerging players that lack in-house infrastructure for large-scale trials, making CRO partnerships a cost-effective solution.
By geography, the CRO Services market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is expected to register the highest growth rate during the forecast period, owing to the presence of high-growth hotspots such as India, China, and Japan that are focused on advancing research capabilities. The growing prevalence of chronic diseases has further fueled the need to outsource clinical services & research activities to CROs, thus supporting the market growth of this region during the forecast period.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=167410116
The market for CRO services is competitive, with key players strategizing to capture the market. Prominent players in the CRO services market are IQVIA Inc. (US), Laboratory Corporation of America Holdings (US), Thermo Fisher Scientific Inc. (US), ICON Plc (Ireland), WuXi AppTec (China), Syneos Health (US), and Charles River Laboratories (US), among others.
IQVIA Inc. (US):
IQVIA Inc. is a global leader in clinical research services, distinguished by its blend of large-scale healthcare data, advanced analytics, and technology-enabled trial delivery. The company's strategic focus is accelerating Phase I to IV execution through site & patient network orchestration, decentralized & hybrid trial models, and AI-driven feasibility, recruitment, and monitoring. Its portfolio spans clinical operations, medical writing, pharmacovigilance, and post-approval studies, integrated with real-world evidence and regulatory strategy support. IQVIA continues to invest in digital patient engagement, remote assessments, and risk-based quality management to streamline timelines and improve data integrity. For instance, in June 2025, IQVIA launched custom-built AI agents using NVIDIA technology designed to enhance workflows and accelerate insights for life sciences.
ICON plc (Ireland)
ICON plc is another key player in the CRO services market, strategically emphasizing end-to-end clinical development and flexible functional service partnerships for pharma, biotech, and medtech clients. The company differentiates through operational excellence, program governance, and digital tools that enhance patient recruitment, eConsent, and remote data capture. ICON's therapeutic strengths include oncology, rare diseases, cell and gene therapy, vaccines, and infectious diseases, supported by specialized biomarker and late-phase capabilities. The acquisition of PRA Health Sciences (US) has added scale, diversified expertise, and deeper relationships with large sponsors while preserving agility for emerging biotechs.
Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific delivers comprehensive CRO services across early and late-phase development, emphasizing operational speed, quality, and patient-centric design through its subsidiary, PPD, Inc. Strategically, PPD leverages Thermo Fisher's broader ecosystem, including central labs, bioanalytical testing, and enabling technologies, to integrate laboratory science with clinical execution for more seamless, data-rich trials. Its capabilities span clinical operations, medical writing, pharmacovigilance, peri- and post-approval research, with growing use of decentralized assessments and digital patient engagement to reduce burden and improve retention.
For more information, Inquire Now!
Related Reports:
Clinical Trial Supplies Market
Pharmaceutical Contract Manufacturing Market
Drug Discovery Services Market
Biologics Safety Testing Market
Get access to the latest updates on Contract Research Organization Services Companies and Contract Research Organization Services Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
Share this article